Drug profile · INN
betamethasone acetate + betamethasone sodium phosphate
CELESTONE CHRONODOSE
betamethasone acetate + betamethasone sodium phosphate (CELESTONE CHRONODOSE) is an FDA-listed pharmaceutical active ingredient. Associated with Organon Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — betamethasone acetate + betamethasone sodium phosphate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
betamethasone acetate + betamethasone sodium phosphate (CELESTONE CHRONODOSE) is an FDA-listed pharmaceutical active ingredient. Associated with Organon Pharma Pty Ltd.
Key facts
INN betamethasone acetate + betamethasone sodium phosphate
Brand CELESTONE CHRONODOSE
Originator Organon Pharma Pty Ltd
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is betamethasone acetate + betamethasone sodium phosphate?
betamethasone acetate + betamethasone sodium phosphate (CELESTONE CHRONODOSE) is an FDA-listed pharmaceutical active ingredient. Associated with Organon Pharma Pty Ltd.
What is the brand name for betamethasone acetate + betamethasone sodium phosphate?
CELESTONE CHRONODOSE is a marketed brand name for betamethasone acetate + betamethasone sodium phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.